- Herbs & Botanicals
- Business Resources
- Natural Product Development
- Legal Compliance
CBD opportunity: Smart brands capitalize on market expansionCBD opportunity: Smart brands capitalize on market expansion
Despite regulatory ambiguity, the hemp-derived cannabidiol (CBD) market generated $390 million for 2018 in the United States. Conservative estimates place the market at more than a billion dollars by 2020. The late December passage of the 2018 Farm Bill legalized hemp and hemp derivatives, including CBD. Although FDA has maintained its position against the use of CBD in food and dietary supplements, the agency hinted a pathway forward may exist.
January 31, 2019
Takeaways for your business
• Investors are taking an increasing interest in the market for hemp-derived CBD.
• Hemp-derived CBD at or below 0.3% THC is no longer considered a controlled substance.
• Globally, CBD and THC appear in supplements, topical analgesics, beverages and skin care products.
You May Also Like
Beyond vaginal microbiota: Emotional well-being, gut health support – white paperNov 22, 2023
Unrivaled performance: Game-changing nutrition for athletes – infographicNov 30, 2023
NPA challenges constitutionality of NY law that restricts sale of weight loss, muscle building supplementsDec 05, 2023
Magnesium's resurgence: A standout at Natural Products Expo East 2023Dec 05, 2023